An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
Status:
Recruiting
Trial end date:
2024-03-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of BMS-986165 compared to
placebo in participants with moderately to severely active Crohn's Disease.